• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A DE C.V. BD MAXZERO PRESSURE RATED EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A DE C.V. BD MAXZERO PRESSURE RATED EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number MP5301-C
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/12/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the bd maxzero pressure rated extension set had leakage.The following information was provided by the initial reporter: product leaking at the point between the needleless connecter and the iv tubing.Allowed blood backflow.Removed product and replaced with a second extension set.Additional information received from the customer: what medication was being administered and leaked.Was this a chemotherapy drug? saline was being flushed through.No medication.What was the impact to the patient? the impact to the patient was that the iv had to be taken back down to the hub to have the device replaced and redressed.Getting an iv on a child is difficult, and this device change added to the stress of iv placement for the child.
 
Additional Manufacturer Narrative
E.1.Address was not located, and (b)(6) was used.H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Additional Manufacturer Narrative
One sample model mp5301-c was returned for investigation.The set was examined for defects and abnormalities.The maxplus was separated from the female luer.No other defects or abnormalities were observed.The customer complaint was verified and a quality notification was sent to the manufacturer.From the manufacturer's investigation, separation between female luer and maxplus could be related lack of solvent and not correctly screw in maxplus to female luer.Additionally, fixture go no go was not used to verify that the components were correctly assembled by the assembler as established in the work instructions.Sku was deactivated in hermosillo site and reactivated at the tj site.A device history record review was performed.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAXZERO PRESSURE RATED EXTENSION SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A DE C.V.
parque sur, el realito
blvd. 2000
tijuana 22250
MX  22250
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana 22250
MX   22250
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key23770729
Report Number9616066-2025-03737
Device Sequence Number9743313
Product Code FPA
UDI-Device Identifier10885403236655
UDI-Public(01)10885403236655(10)25089073
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K083472
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/03/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue NumberMP5301-C
Device Lot Number25089073
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/12/2025
Supplement Date Received by Manufacturer02/03/2026
Initial Report FDA Received Date12/10/2025
Supplement Report FDA Received Date02/03/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/27/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-